These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24060860)

  • 1. Genomics: Mutator catalogues.
    Alderton GK
    Nat Rev Cancer; 2013 Oct; 13(10):681. PubMed ID: 24060860
    [No Abstract]   [Full Text] [Related]  

  • 2. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
    Roberts SA; Lawrence MS; Klimczak LJ; Grimm SA; Fargo D; Stojanov P; Kiezun A; Kryukov GV; Carter SL; Saksena G; Harris S; Shah RR; Resnick MA; Getz G; Gordenin DA
    Nat Genet; 2013 Sep; 45(9):970-6. PubMed ID: 23852170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signatures of mutational processes in human cancer.
    Alexandrov LB; Nik-Zainal S; Wedge DC; Aparicio SA; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale AL; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinski M; Jäger N; Jones DT; Jones D; Knappskog S; Kool M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt AN; Valdés-Mas R; van Buuren MM; van 't Veer L; Vincent-Salomon A; Waddell N; Yates LR; ; ; ; ; Zucman-Rossi J; Futreal PA; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR
    Nature; 2013 Aug; 500(7463):415-21. PubMed ID: 23945592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer genomics: Signature analysis suggests cancer origins.
    Lokody I
    Nat Rev Genet; 2013 Oct; 14(10):677. PubMed ID: 23982625
    [No Abstract]   [Full Text] [Related]  

  • 5. [APOBEC3B-induced mutagenesis in cancers].
    Takaori-Kondo A
    Seikagaku; 2016 Oct; 88(5):576-81. PubMed ID: 29624320
    [No Abstract]   [Full Text] [Related]  

  • 6. Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features.
    Buisson R; Langenbucher A; Bowen D; Kwan EE; Benes CH; Zou L; Lawrence MS
    Science; 2019 Jun; 364(6447):. PubMed ID: 31249028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics: Signatures of mutational processes in cancer-a big step closer.
    Hutchinson L
    Nat Rev Clin Oncol; 2013 Oct; 10(10):545. PubMed ID: 23999215
    [No Abstract]   [Full Text] [Related]  

  • 8. [Genomic mutator Activation-induced cytidine deaminase (AID) as a therapeutic target].
    Kotani A
    Rinsho Ketsueki; 2014 Jul; 55(7):780-4. PubMed ID: 25098513
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer: When catastrophe strikes a cell.
    Tubio JM; Estivill X
    Nature; 2011 Feb; 470(7335):476-7. PubMed ID: 21350479
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutational showers during carcinogenesis.
    Kaufmann WK
    Pigment Cell Melanoma Res; 2012 Sep; 25(5):566-8. PubMed ID: 22765291
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of activation-induced cytidine deaminase in inflammation-associated cancer development.
    Marusawa H; Takai A; Chiba T
    Adv Immunol; 2011; 111():109-41. PubMed ID: 21970953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers.
    Mas-Ponte D; Supek F
    Nat Genet; 2020 Sep; 52(9):958-968. PubMed ID: 32747826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription-coupled mutagenesis by the DNA deaminase AID.
    Larson ED; Maizels N
    Genome Biol; 2004; 5(3):211. PubMed ID: 15003109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.
    Chan K; Roberts SA; Klimczak LJ; Sterling JF; Saini N; Malc EP; Kim J; Kwiatkowski DJ; Fargo DC; Mieczkowski PA; Getz G; Gordenin DA
    Nat Genet; 2015 Sep; 47(9):1067-72. PubMed ID: 26258849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics: the breast cancer landscape.
    Gray J; Druker B
    Nature; 2012 Jun; 486(7403):328-9. PubMed ID: 22722187
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetics: APOBEC-a double-edged sword.
    Razzak M
    Nat Rev Clin Oncol; 2013 Sep; 10(9):488. PubMed ID: 23897082
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic inflammation facilitates transcription-associated mutagenesis via AID activity and enhances liver tumorigenesis.
    Matsumoto T; Shimizu T; Nishijima N; Ikeda A; Eso Y; Matsumoto Y; Chiba T; Marusawa H
    Carcinogenesis; 2015 Aug; 36(8):904-13. PubMed ID: 25969143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOBEC3B mutagenesis in cancer.
    Kuong KJ; Loeb LA
    Nat Genet; 2013 Sep; 45(9):964-5. PubMed ID: 23985681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
    Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
    Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
    Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
    Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.